Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy

Area of Science:

• Neurology
• Epidemiology
• Public Health

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• Tracheostomy is a potential intervention for respiratory failure in ALS patients.
• Understanding tracheostomy outcomes in ALS is crucial for patient care and resource allocation.

Purpose of the Study:

• To evaluate the clinical characteristics and outcomes of tracheostomy in amyotrophic lateral sclerosis (ALS).
• To identify factors influencing tracheostomy rates and survival in an epidemiological setting.

Main Methods:

• Analysis of a prospective epidemiological register (Piemonte and Valle d'Aosta Register for ALS).
• Inclusion of 1260 incident ALS cases from 1995-2004.
• Evaluation of 134 patients who underwent tracheostomy, including survival analysis using Cox multivariable models.

Main Results:

• 10.6% of ALS patients underwent tracheostomy; young males were more likely to receive it.
• Median survival post-tracheostomy was 253 days (less than a year).
• Enteral nutrition, younger age, marital status, and ALS center follow-up were associated with longer survival.

Conclusions:

• In an epidemiological context, tracheostomy for ALS patients results in survival of less than one year.
• Sociocultural factors significantly influence the decision for tracheostomy, irrespective of the healthcare system's socialized nature.
• Further research into patient and family preferences is warranted.